Immunoglobulin class-switch recombination (CSR) requires activation-induced cytidine deaminase (AID). Deamination of DNA by AID in transcribed switch (S) regions leads to double-stranded breaks in DNA that serve as obligatory CSR intermediates. Here we demonstrate that the catalytic and regulatory subunits of protein kinase A (PKA) were specifically recruited to S regions to promote the localized phosphorylation of AID, which led to binding of replication protein A and subsequent propagation of the CSR cascade. Accordingly, inactivation of PKA resulted in considerable disruption of CSR because of decreased AID phosphorylation and recruitment of replication protein A to S regions. We propose that PKA nucleates the formation of active AID complexes specifically on S regions to generate the high density of DNA lesions required for CSR.
Immunoglobulin class-switch recombination (CSR) requires activation-induced cytidine deaminase (AID). Deamination of DNA by AID in transcribed switch (S) regions leads to double-stranded breaks in DNA that serve as obligatory CSR intermediates. Here we demonstrate that the catalytic and regulatory subunits of protein kinase A (PKA) were specifically recruited to S regions to promote the localized phosphorylation of AID, which led to binding of replication protein A and subsequent propagation of the CSR cascade. Accordingly, inactivation of PKA resulted in considerable disruption of CSR because of decreased AID phosphorylation and recruitment of replication protein A to S regions. We propose that PKA nucleates the formation of active AID complexes specifically on S regions to generate the high density of DNA lesions required for CSR.
Antibodies are composed of immunoglobulin heavy chains and light chains, with an amino-terminal variable (V) region involved in antigen binding and a carboxy-terminal constant (C) region required for the effector function. During early B cell development in fetal liver and adult bone marrow, the genes encoding the heavy-chain and lightchain V regions are assembled from component V, diversity (D) and joining (J) gene segments by the process of V(D)J recombination 1 . The productive assembly of heavy chains and light chains generates a mature B cell that expresses immunoglobulin M (IgM) on its surface. The mature B cells subsequently migrate to the secondary lymphoid organs such as the spleen and lymph nodes, where they encounter antigens and undergo two additional rounds of genetic alteration in the forms of class-switch recombination (CSR) and somatic hypermutation (SHM) [2] [3] [4] [5] .
CSR results in a change in the heavy-chain constant region (C H ) from C m to other downstream C H regions (C g 3, C g 1, C g 2b, C g 2a, C e and C a , all encoded in the mouse Igh locus) so that secondary isotypes (IgG, IgE and IgA) with different effector functions are generated 3, 4 . CSR occurs in repetitive DNA elements 1-12 kilobases in length, called 'switch' (S) regions, that precede each C H gene. The C H genes are organized as independent transcription units 3, 4 . Transcription is initiated from a cytokine-inducible intronic (I) promoter upstream of an I-exon, proceeds through the S regions and terminates downstream of the C H exons. The primary transcript is spliced to remove the intronic S region, thereby joining the I and C H exons to generate a polyadenylated, noncoding germline transcript. Mutations of promoters or enhancers that impair germline transcription through particular C H genes impair CSR to that particular isotype, which shows that transcription serves an important mechanistic function in CSR 3, 4 .
In addition to S regions and transcription, CSR absolutely requires participation of the activated B cell-specific protein AID 6, 7 . AID is a single-stranded DNA (ssDNA)-specific DNA cytidine deaminase [8] [9] [10] [11] [12] , and the ability of AID to deaminate its target sequences is intimately linked to transcription 3 . Transcription through S regions, which are rich in guanosine and cytidine with a characteristic guanosine-rich nontemplate strand, generates RNA-DNA hybrid structures, such as R loops, that displace the nontemplate strand as ssDNA [13] [14] [15] . In vitro studies have shown that AID can efficiently deaminate cytidine to uridine in R loops 10 . The deaminated S regions are then processed by proteins of the base excision-repair pathway (such as uracil DNA glycosylase) and mismatch-repair pathway (such as Msh2) to ultimately generate DNA double-stranded breaks (DSBs) [16] [17] [18] [19] . General DNA-repair pathways synapse and join DSBs between two broken S regions to complete CSR 3 .
Mature B cells also undergo SHM, a process by which point mutations are introduced at a very high rate into V-region exons of the heavy-chain and light-chain genes, leading to the selection of antibodies with higher affinity 2, 5 . The mechanism by which SHM is initiated is related to CSR in that it requires AID and transcription, in this case through the V-gene segments. However, unlike S regions, V genes are not rich in guanosine and cytidine and therefore do not readily provide ssDNA substrates for AID. Biochemical studies have shown that AID interacts with replication protein A (RPA), and the AID-RPA complex can bind to and stabilize ssDNA in transcribed V genes to mediate deamination 20 . Thus, although AID is essential for both CSR and SHM 6, 7 , the mechanism by which AID accesses the target sequences is different for the two reactions 3 .
Although immunoglobulin sequences are the main physiological targets of AID, several transcribed non-immunoglobulin genes are also mutated by AID [21] [22] [23] . Non-immunoglobulin gene targets of AID are of particular relevance to B cell lymphomagenesis, as most mature B cell lymphomas have mutations and translocations of oncogenes, such as MYC and BCL6, and AID has been directly linked to the initiation of such oncogenic events [24] [25] [26] [27] . AID activity and expression is thus carefully regulated at many levels, including B cell-specific expression 28 and destabilization of its mRNA mediated by microRNA 29, 30 , as well as proteolysis 31 and phosphorylation 20, [32] [33] [34] [35] . However, none of those regulatory processes can explain how AID-induced DSBs are restricted mainly to S regions in a B cell actively undergoing CSR when AID and its cofactor RPA are abundant. Here we propose that the specificity of AID-induced DNA lesions is achieved in part by the recruitment of its activating kinase, protein kinase A (PKA), exclusively to S regions during CSR.
RESULTS
Phosphorylation of AID at Ser38 by PKA regulates CSR AID in activated B cells is phosphorylated at the serine residue at position 38 (Ser38) 20, 32, 34, 36 . Ser38 is in a consensus cAMP-dependent PKA-phosphorylation site. Recombinant AID can be phosphorylated in vitro at Ser38 by PKA, and the phosphorylated AID (pSer38-AID) acquires the ability to interact with RPA and mediate deamination of SHM targets 32 . We substituted the serine at the Ser38 phosphorylation site with alanine, followed by retroviral expression of the resulting mutant protein AID(S38A) in AID-deficient mouse splenic B cells. In agreement with early published observations 32, 34, 35 and in contrast to subsequent reports 37 , AID(S38A) was substantially impaired in its ability to restore CSR to AID-deficient splenic B cells (Fig. 1a) .
Additional evidence that PKA activates CSR was provided by in vitro overexpression studies. After retroviral overexpression of an epitope-tagged PKA catalytic subunit (PKA-Ca; A001914) in splenic B cells stimulated with lipopolysaccharide (LPS) and interleukin 4 (IL-4), immunoblot analysis showed that expression of the exogenous PKA-Ca was approximately twofold more than that of endogenous PKA-Ca ( Supplementary Fig. 1 online) . Wild-type B cells that overexpressed PKA-Ca had a percentage of IgG 1 + cells approximately 40-50% higher than that of cells expressing the vector control ( Fig. 1b and Supplementary Fig. 2 online) . The greater CSR frequency was not due to enhanced B cell proliferation ( Supplementary  Fig. 3a ,b online) or germline transcription ( Supplementary Fig. 4 online). Experiments with B cells that expressed a catalytically inactive PKA-Ca mutant (K73M) 38 were inconclusive, as we were unable to detect the mutant protein in the retrovirally infected B cells ( Supplementary Fig. 1 ). Overexpression of Pim1 (Supplementary Fig. 1 ), a kinase that does not phosphorylate AID, did not increase CSR ( Supplementary Fig. 5 online). Thus, many lines of evidence suggest that phosphorylation of AID at Ser38 by PKA is important in CSR in vivo.
AID phosphorylation is not needed for S-region binding
The substantial CSR defect in cells expressing AID(S38A) would not have been predicted by prevailing CSR models, which posit that ssDNA in the context of R loops represents a suitable AID target and thus would not require RPA-mediated stabilization 20 . Indeed, whereas AID(S38A) purified from B cells was considerably compromised in its ability to deaminate an SHM target in vitro, the mutant protein was as competent as wild-type AID (AID(WT)) in mediating deamination of a transcribed S region (Fig. 2a) . These results reiterate the idea that phosphorylation of AID is dispensable for deamination of R loop-forming substrates. To determine if the CSR defect in AID(S38A) cells was due to less binding of AID(S38A) to S regions, we did chromatin immunoprecipitation (ChIP) experiments. We cultured AID-deficient splenic B cells ex vivo and infected them with retrovirus expressing AID(WT) or AID(S38A) or with the control retroviral vector (pMIG), then immunoprecipitated crosslinked DNA-protein complexes with polyclonal AID-specific antibodies. We analyzed the immunoprecipitated DNA for the presence of S m and S g 1, regions that are active for CSR in conditions of stimulation. We found that AID(S38A) and AID(WT) associated with S m and S g 1 to a similar extent (Fig. 2b) . There was no detectable binding of AID to either S g 3, an S region that is not a recombination target in cells cultured with LPS plus IL-4, or the Igh I m promoter. These results demonstrate that phosphorylation of AID at Ser38 is not essential for its association with S regions. However, in B cells expressing AID(S38A), RPA could not be recruited to S regions (Fig. 2b) , consistent with the idea that the interaction between AID and RPA is phosphorylation dependent 20, 39 . Overall, these experiments indicate that the defect in CSR in AID(S38A)-expressing cells was not due to a failure of AID to access S regions but instead was due to an inability to recruit RPA. The ability of AID(S38A) to efficiently associate with S regions prompted us to investigate if pSer38-AID was present at S regions. For this, we raised a monoclonal antibody (9B2) to pSer38-AID. In immunoblots of protein extracts derived from cells expressing both AID and PKA-Ca, 9B2 reacted specifically with a polypeptide that migrated with the same mobility as AID (Supplementary Figs. 6 and 7 online). There was no reactivity with AID(S38A) (Supplementary Figs. 6 and 7) or with an unphosphorylated peptide encompassing the Ser38 residue ( Supplementary Fig. 8 online) , which indicated that the antibody was specific to pSer38-AID. In ChIP experiments, 9B2 readily detected pSer38-AID at S m and S g 1, but not at the control regions p53 and AID, in AID-deficient B cells infected with retrovirus expressing AID(WT) (Fig. 2c) . There was no amplification of S regions in immunoprecipitated DNA from AID-deficient B cells transduced with AID(S38A) or the control vector pMIG (Fig. 2c) . These results demonstrate that pSer38-AID is present on S regions undergoing CSR.
PKA subunits are recruited to S regions during CSR The results presented above suggested that PKA activates CSR by phosphorylating, and thus regulating, AID activity. As PKA is a generally expressed kinase with many characterized substrates 40 and AID can deaminate ssDNA indiscriminately in vitro 10-12 , we reasoned that specificity for AID activity might be restricted in vivo by localized phosphorylation of AID bound to S regions in B cells undergoing CSR. Notably, PKA, which is typically anchored in subcellular compartments to limit its kinase activity, is recruited to actively transcribed genes 41 . In unactivated cells, the PKA holoenzyme consists of two regulatory and two catalytic subunits; the phosphotransferase activity of the catalytic subunits is inhibited by the regulatory subunits. Activation and release of the catalytic subunit is mediated by cAMP, which binds allosterically to the regulatory subunits in the holoenzyme 42 . Mouse splenic B cells expressed mRNA encoding the regulatory subunits PKA-RIa (A000049) and PKA-RIIa (A001918), as well as the catalytic subunits PKA-Ca and PKA-Cb (A001915); however, they did not express mRNA encoding the regulatory subunits PKA-RIb and PKA-RIIb (A000050; Supplementary Fig. 9 online) . In CSR-stimulated splenic B cells, PKA subunits were present in the cytoplasm, nucleus and chromatin fractions ( Supplementary Fig. 10 online) . To determine whether PKA subunits are recruited to S regions during CSR, we did ChIP experiments with antibodies to PKA subunits, using wild-type B cells stimulated with LPS plus IL-4. We found the catalytic subunit PKA-Ca at S m and S g 1 but not at S g 3 (Fig. 3a) . Notably, the regulatory subunit PKA-RIa also bound the active S regions (Fig. 3a) , which suggested that the PKA holoenzyme was associated with the Igh locus. ChIP experiments with antibodies to the subunits PKA-Cb and PKA-RIIa were not reproducible and the association of these subunits with S regions could not be determined (data not shown). There was no detectable binding of the PKA subunits to other control genomic sequences, such those derived from Aicda (which encodes AID) or Trp53 (which encodes p53; Fig. 3a ), or to several other genes that are upregulated or downregulated in cells undergoing CSR ( Supplementary Fig. 11 online) .
The association of PKA subunits with S regions was specific to cells activated for CSR and could be detected as early as 13 h after stimulation ( Supplementary Fig. 12 online) . We did not detect PKA at S regions in unstimulated splenic B cells or in B cells cultured ex vivo with antibody to CD40 (anti-CD40), which induces proliferation but not CSR (Fig. 3b) . Additionally, there were no PKA subunits at S regions in proliferating splenic T cells (Fig. 3b) . As AID has been found to interact with the PKA holoenzyme 32, 33 ( Supplementary Fig. 6 ), we tested the possibility that the association of PKA with S regions is mediated by AID. ChIP experiments with activated AID-deficient B cells showed that the PKA subunits were still bound to S regions (Fig. 3c) , which indicated that the binding was AID independent. Similar to results obtained with unstimulated wild-type B cells, we did not detect PKA at S regions in unstimulated splenic B cells derived from AID-deficient mice (Supplementary Fig. 13 online) . The experiments reported above demonstrate that the subunits PKA-Ca and PKA-RIa are specifically recruited to S regions in B cells activated for CSR and that the formation of the PKA-S region complex is AID independent.
PKA, AID and RPA form a complex on S regions
To determine if the proteins (PKA, RPA and AID) shown to be associated with S regions are in the same macromolecular complex, we did two-step ChIP experiments. In these assays, we purified DNAprotein complexes with one set of antibodies and subjected them to a second round of ChIP with a different set of antibodies (anti-PKA-RIa, anti-PKA-Ca or anti-RPA). We used nonspecific IgG in the second round of ChIP as a control for the 'carryover' of antibody from the first ChIP. In experiments in which the first ChIP used anti-AID, followed by secondary ChIP with anti-PKA-RIa or anti-PKA-Ca, S m was readily detected in the DNAprotein complex (Fig. 4a) , which indicated that AID was bound to S m that also contained both PKA subunits. Likewise, two-step ChIP experiments with anti-RPA as the primary ChIP antibody showed that RPA, PKA-Ca and PKA-RIa were in a complex with S m (Fig. 4b) . As binding of RPA to S regions depends on pSer38-AID, and phosphorylation of AID by PKA-Ca requires the release of PKA-RIa from the PKA holoenzyme, phosphorylation of AID must occur without physical displacement of the PKA-RIa subunit from the chromatin. Whether PKA, AID and RPA are directly bound to each other on the DNA remains unclear; however, our data suggest that a complex of AID, RPA and PKA is assembled at the S regions to locally phosphorylate AID and initiate the early stages of CSR.
Genetic inactivation of PKA impairs CSR
To directly demonstrate that PKA activity regulates CSR, we used the 'RIaB' mutant mouse, which contains a G324A substitution in the cAMP-binding site of PKA-RIa that diminishes the affinity of PKARIa for cAMP by two orders of magnitude 43 . Thus, the mutant PKARIa protein remains bound to the catalytic subunit at relatively high concentrations of cellular cAMP, which effectively decreases cellular PKA activity. We bred RIaB mice to Cd21-Cre-transgenic mice (which express Cre recombinase driven by the Cd21 promoter) to delete the neomycin-resistance cassette in the mutated RIaB allele (RIaB:Cd21-Cre; Supplementary Fig. 14 online) specifically in mature B cells 44 . B cells from RIaB:Cd21-Cre mice had much less overall PKA activity (Fig. 5a) . Next, we activated splenic B cells from RIaB:Cd21-Cre mice ex vivo with LPS or with LPS plus IL-4 to promote CSR to IgG3 or IgG1, respectively. B cells from RIaB:Cd21-Cre mice had 35-50% less CSR than did control cells from their wild-type littermates (Fig. 5b) . The diminished CSR was not accompanied by less AID or PKA protein or germline transcription or less cell proliferation (Supplementary Figs. 15-17 online) . Thus, genetic suppression of PKA activity in B cells impairs CSR.
Finally, we did ChIP experiments to determine how the lower PKA activity affected the recruitment of various CSR factors to S regions. For this set of experiments, we analyzed input and immunoprecipitated DNA samples by quantitative real-time PCR. The lower PKA activity had no effect on the amount of PKA subunits associated with S regions (Fig. 5c) . In addition, the amount of AID bound to S regions was similar in wild-type and RIaB:Cd21-Cre cells, consistent with the data reported above demonstrating that phosphorylation of AID at Ser38 did not regulate its recruitment to the Igh locus (Fig. 2b) . Notably, however, there was much less association of phosphorylated AID and RPA with S regions (Fig. 5c) , which provides unequivocal genetic evidence that impaired PKA activity leads to less phosphorylated AID at S regions, with concomitantly less recruitment of RPA and CSR. The hypomorphic nature of the RIaB mutation allowed measurable phosphorylation of AID and recruitment of RPA to S regions (Fig. 5c and Supplementary Fig. 18 online) and could account for the finding that the CSR defect in RIaB:CdD21-Cre cells was less severe than that in B cells expressing AID(S38A).
The results reported above led us to propose a model in which a CSR stimulus assembles AID and PKA at activated S regions (Supplementary Fig. 19 online) . The PKA-RIa subunit associated with the PKA holoenzyme maintains AID in an unphosphorylated state until a burst of cAMP activates PKA-Ca, which leads to phosphorylation of AID, recruitment of RPA and activation of CSR ( Supplementary  Fig. 19 ). In agreement with our model, both wild-type and AIDdeficient splenic B cells stimulated to undergo CSR had a three-to fourfold increase in cAMP between 24 and 48 h, followed by a gradual decrease between 48 and 96 h (Fig. 6) . Overall, our findings that AID can be recruited to S regions without phosphorylation at Ser38, the underlying prediction that PKA phosphorylates S region-bound AID, and the observed increase in cAMP at a time that coincides with CSR provide a satisfactory model whereby synchronous phosphorylation of multiple AID molecules generates the high density of DSBs required for efficient CSR 45 .
DISCUSSION
AID can deaminate S regions in vitro and bind to S regions in B cells independently of its phosphorylation status. Yet efficient CSR requires phosphorylation of AID at Ser38 (refs. 32-35,46) , which suggests a phosphorylation-dependent post-deamination function for AID. The only known biochemical function for phosphorylation of AID at Ser38 is to promote interaction with RPA, as compensatory substitutions in AID(S38A) that allow constitutive binding to RPA can restore CSR activity 39 . Thus, AID 'activity' during CSR includes both its enzymatic activity (DNA deamination) as well as its ability to recruit RPA to S regions.
The precise function of RPA in CSR is not clear, but it may act 'downstream' of deamination, as in the recruitment of uracil DNA glycosylase or mismatch-repair proteins, which convert deaminated cytidines to DSBs 4 . Additionally, RPA might recruit proteins such as 53BP1 and H2AX to DSBs to promote synapsis between distal broken S regions before their ligation during CSR. The known requirements for uracil DNA glycosylase, mismatch-repair proteins, 53BP1 and H2AX in CSR and the reported interactions of those proteins with RPA support the idea that RPA is involved 'downstream' of DNA deamination 3 . Failure to recruit RPA to S regions could thus impair conversion of the deaminated residues into DSBs or the interaction between distal DSBs. Either defect or both defects could be manifested as a considerable defect in CSR. The residual CSR in cells expressing AID(S38A) probably reflects the ability of unphosphorylated AID to bind to and deaminate S regions, a few of which could be converted into nicks and DSBs, and a productive recombination reaction with a 'downstream' S region by an RPA-independent mechanism. Thus, it is possible that low frequencies of CSR could occur in the absence of assembled PKA complexes. That idea is consistent with the observation that the artificial generation of DSBs in S regions can allow CSR, albeit less CSR, in the absence of AID 47 . Thus, the function of RPA in CSR is possibly distinct from that in SHM, in which the AID-RPA interaction is needed to permit access of AID to transcribed V genes 20 .
The PKA-dependent activation of AID has several potential implications for the prevention of inadvertent DNA lesions. First, the sequestration of AID in an inactive PKA holoenzyme complex 32, 33 could effectively limit the total cellular concentration of active AID. Second, the specific recruitment of both AID and PKA to S regions ensures activity only in the context of physiological targets. Thus, whereas AID can deaminate and mutate several transcribed genes in germinal center B cells at a very low rate 23 , its full DSBgenerating activity, as required for CSR, is 'unmasked' only when it is recruited together with PKA, which thereby effectively restricts AID-dependent mutagenesis at non-immunoglobulin genes. Finally, the AID-independent recruitment of PKA to activated S regions and the ability of AID to interact with PKA lead us to hypothesize that PKA itself could be the factor that targets AID to S regions during CSR.
The data presented here provide evidence of a mammalian serinethreonine kinase that is recruited to S regions to activate CSR. The mechanism by which the PKA subunits are 'ferried' and tethered to the S regions is unclear; however, PKA (and possibly AID) may associate with a specific transcription factor or an unknown 'targeting factor' that recruits it (or them) to the S regions during CSR. In this context, binding sites for the cAMP-response element-binding protein, a well characterized PKA substrate, have been found in the germline promoters of S a and S g 1, and cAMP-response elementbinding protein has been shown to regulate germline transcription 'downstream' of transforming growth factor-b stimulation 48 . Alternatively, the recruitment of PKA to S regions may be mediated by A kinase-anchoring proteins. Hypothetical B cell A kinase-anchoring proteins would coordinate the enzymes and substrates required for CSR to permit efficient activation of AID by juxtaposing AID with its substrate (DNA), its activator (PKA) and its cofactor (RPA). Regardless of the mechanism of the recruitment of PKA to S regions, the association of PKA with S regions is consistent with the hypothesis that localized activation of PKA through cAMP microdomains directs PKA activity toward specific substrates. The phosphorylation and activation of AID by PKA directly on the target DNA thus sets a paradigm for the way a generally expressed kinase achieves specificity for its substrate by concerted recruitment of both to a specific subcellular compartment.
METHODS
Mouse models, B cell purification and retroviral infection. Aicda -/-mice were a gift from T. Honjo. Wild-type BALB/c and Cd21-Cre mice were from The Jackson Laboratory. RIaB mice were generated as described 43 . All animals were maintained according to guidelines for animal welfare of the Memorial-Sloan Kettering Research Animal Resource Center.
Mouse splenic B cells were purified by negative selection with anti-CD43 magnetic beads (Miltenyi Biotec) and were stimulated with LPS (10 mg/ml), with LPS (10 mg/ml) plus IL-4 (12.5 mg/ml) or with anti-CD40 (1 mg/ml; HM40-3; eBioscience) plus IL-4. Cells were labeled with the cytosolic dye CFSE (carboxyfluorescein diacetate succinimidyl diester) as described 49 . Mouse splenic T cells were purified by negative selection with the Pan T Cell Isolation kit (Miltenyi Biotec) and were stimulated with platebound anti-CD3 and anti-CD28 (a gift from J. Allison). Retroviral infection was done as described 50 .
ChIP. ChIP was done as described 51 . PCR primers are in Supplementary Table 1 online). Two-step ChIP was done as described 52 .
A LightCycler DNA Master SYBR Green I kit (Roche) was used for real-time PCR of immunoprecipitated DNA (primers, Supplementary Table 1) . Realtime PCR products were analyzed for incorporation of SYBR Green and crossing points were obtained with the Lightcycler software. Melting-curve analysis and agarose gels confirmed the presence of a single PCR product of the predicted size. 'Relative units' for ChIP were calculated by normalization of the crossing point of ChIP with each specific antibody to the crossing point of the input DNA; the inverse of the input DNA-normalized crossing point was then calculated. The 'IgG-preclear' value (inverse of the input DNA-normalized crossing point) was subtracted from value obtained for ChIP with each specific antibody (inverse of the input DNA-normalized crossing point) to obtain the 'relative units' for ChIP.
Plasmids. The retroviral vector pMIG has been described 50 . Additional plasmid descriptions are in the Supplementary Methods online. The cDNA encoding PKA-Ca, PKA-Cb, PKA-RIa and PKA-RIIa was obtained by RT-PCR of splenic B cell RNA and was subsequently cloned into pCDNA3.1/HisC (Invitrogen) to obtain Xpress epitope-tagged PKA subunits.
Xpress-tagged PKA-Ca and PKA-Cb were cloned into the multiple cloning sites of pMIG; untagged PKA-RIa and PKA-RIIa were cloned into pMIG. The cDNA encoding mouse AID (AID(WT) or AID(S38A)) with both Flag and hemagglutinin epitope tags on the amino terminus was generated by PCR amplification and was subsequently cloned into the multiple cloning site of pMIG. The plasmid pMIG-hPim1 was obtained from P. Rothman.
Reagents and antibodies. Antibodies for ChIP were as follows: anti-PKA-Ca (sc-903; Santa Cruz Biotechnology), anti-PKA-RIa (sc-28893; Santa Cruz Biotechnology), anti-AID (as described 10 ), anti-RPA (NA19L; Oncogene), anti-H3 (ab12079; Abcam) and anti-rabbit IgG (I5006; Sigma). Antibodies for flow cytometry were as follows: allophycocyanin-anti-IgG1 (X56), phycoerythrin-indotricarbocyanine-anti-B220 (RA3-6B2) and fluorescein isothiocyanate-anti-IgG3 (R40-82; all from BD Pharmingen). Antibodies for immunoblot analysis were as follows: anti-Xpress (R910-25; Invitrogen), anti-PKA-Ca (610981; BD Transduction), anti-PKA-RIa (610610; BD Transduction), anti-PKA-RIIa (612242; BD Transduction), anti-hemagglutinin (3F10; Roche), anti-a-tubulin (T9026; Sigma), anti-b-tubulin (sc-5274; Santa Cruz Biotechnology), anti-Flag (M2; Sigma), anti-GFP (33-2600; Zymed) and anti-Pim-1 (sc-28777; Santa Cruz Biotechnology). Additional antibody descriptions are in the Supplementary Methods.
LPS was from Sigma (L7261), IL-4 was from R&D Systems (404-ML-050), anti-CD40 was from eBiosciences (HM40-3), and anti-CD3 and anti-CD28 were a gift from J. Allison. Additional antibody descriptions are in the Supplementary Methods.
Armenian hamster monoclonal antibody to pSer38-AID (9B2) was generated by the Monoclonal Antibody Core Facility (Memorial Sloan-Kettering Cancer Center). A peptide phosphorylated (*) at Ser38 (CYVVKRRDS*ATS), synthesized at the Keck Biotechnology Resource Center at Yale University, was conjugated to keyhole limpet hemocyanin before immunization of hamsters.
Cell extract fractionation. Cells were separated into cytoplasmic and nuclear fractions as described 53 . Chromatin fractions were obtained by resuspension of the nuclear lysis pellet in five volumes of HCl lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol and 1.5 mM phenylmethyl sulfonyl fluoride). Hydrochloric acid was added to a final concentration of 0.2 M and the samples were kept at 4 1C for 30 min before being spun at 20,000g in a refrigerated micro-centrifuge. The pellet was discarded and the supernatant (chromatin extract) was neutralized with 0.5 volumes of 1 M Tris, pH 8.0.
Assay of cAMP. The amount of cAMP was determined with the cAMP Biotrak Enzymeimmunoassay system (Amersham). B cells (1 Â 10 6 ) in a volume of 1 ml in a 24-well plate were stimulated for various times with LPS plus IL-4. For calculation of cAMP amounts, the absorbance at 450 nm at each time point was compared with a cAMP standard curve.
